Research

Found 30 results

Sort by: Author [ Title (Desc)] Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H [I] J K L M N O P Q R S T U V W X Y Z   [Show ALL]
U
Owens JA, Babcock D, Blumer J, Chervin R, Ferber R, Goetting M, Glaze D, Ivanenko A, Mindall J, Rappley M et al..  2005.  The Use of Pharmacotherapy in the Treatment of Pediatric Insomnia in Primary Care: Rational Approaches. A Consensus Meeting Summary. Journal of Clinical Sleep Medicine. 1(1):49-59.
Ingrassia A, Turk J.  2005.  The Use of Clonidine for Severe and Intractable Sleep Problems in Children with Neurodevelopmental Disorders: A Case Series. Eur Child Adolesc Psychiatry. 14:34-40.
T
Hillier A, Campbell H, Mastriani K, Izzo MV, Kool-Tucker AK, Cherry L, Beversdorf DQ.  2007.  Two-Year Evaluation of a Vocational Support Program for Adults on the Autism Spectrum. Career Development for Exceptional Individuals. 30(1):35-47.
Ingersoll B, Lewis E, Kroman E.  2007.  Teaching the Imitation and Spontaneous Use of Descriptive Gestures in Young Children with Autism Using Naturalistic Behavioral Intervention. J Autism Dev Disord. 37:1446-1456.
Ingersoll B, Schreibman L.  2006.  Teaching Reciprocal Imitation Skills to Young Children with Autism Using a Naturalistic Behavioral Approach: Effects on Language, Pretend Play, and Joint Attention. Journal of Autism and Developmental Disorders. 36(4):487-505.
S
Ichim TE, Solano F, Glenn E, Morales F, Smith L, Zabrecky G, Riordan NH.  2007.  Stem Cell Therapy for Autism. Journal of Translational Medicine. 5:30.
Iarocci G, McDonald J.  2006.  Sensory Integration and the Perceptual Experience of Persons with Autism. J Autism Dev Disord.. 36:77-90.
Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S.  2009.  Safety and Efficacy of Oral DMSA Therapy for Children with Autism Spectrum Disorders: Part B – Behavioral Results. BMC Clinical Pharmacology. 9:17-26. Abstract
Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S.  2009.  Safety and Efficacy of Oral DMSA Therapy for Children with Autism Spectrum Disorders: Part A – Medical Results. BMC Clinical Pharmacology. 9:16-38. Abstract
R
Miral S, Gencer O, Inal-Emirogly FN, Baykara B, Baykara A, Dirik E.  2007.  Risperidone versus Haloperidol in Children and Adolescents with AD: A Randomized, Controlled, Double-Blind Trial. Eur Child Adolesc Psychiatry. 17(1):1-8.
P
toy-play explore IA play, toy.  2003.  Promoting Early Play. Autism. 7(4):415-423.
M
Mundy PC, Henderson HA, Inge AP, Coman DC.  2007.  The Modifier Model of Autism and Social Development in Higher Functioning Children. Research & Practice for Persons with Severe Disabilities. 32(2):124-139.
Golnik A, Ireland M, Borowsky IW.  2009.  Medical Homes for Children with Autism: A Physician Survey. Pediatrics. 123(3):966-971.
L
Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.  2006.  Levetiracetam Versus Placebo in Childhood and Adolescent Autism: A Double-Blind Placebo-Controlled Study. International Clinical Psychopharmacology. 21(6):363-367.
I
Green VA, Pituch KA, Itchon J, Choi A, OReilly M, Sigafoo J.  2006.  Internet Survey of Treatments Used by Parents of Children with Autism. Research in Developmental Disabilities. 27(1):70-84.
H
Sasayama D, Sugiyama N, Imai J, Hayashida A, Harada Y, Amano N.  2009.  High-Dose Paroxetine Treatment for an Adolescent with Obsessive-Compulsive Disorder Comorbid with Asperger’s Disorder. Psychiatry and Clinical Neurosciences. 63(2):251-256.
F
Iacobini M.  2006.  Failure to Deactivate in Autism: The Co-Constitution of Self and Other. Trends Cogn Sci.. 10(10):431-433.
E
Christison GW, Ivany K.  2006.  Elimination Diets in Autism Spectrum Disorders: Any Wheat Amidst the Chaff? J Dev Behav Pediatr.. 27(2(Suppl)):S162-S171.
C
Ijichi S, Ijichi N.  2007.  Computerized Lifelong Mentoring Support Using Robot for Autistic Individuals. Medical Hypotheses. 68(3):493-498.
Golnik AE, Ireland M.  2009.  Complementary Alternative Medicine for Children with Autism: A Physician Survey. Journal of Autism and Developmental Disorders . 39(7):996-1005. Abstract
Whalen C, Schreibman L, Ingersoll B.  2006.  The Collateral Effects of Joint Attention Training on Social Initiations, Positive Affect, Imitation, and Spontaneous Speech for Children with Autism. J. Autism Dev Disord.. 36(5):655-664.
Itzchak EB, Lahat E, Burgin R, Zachor AD.  2008.  Cognitive, Behavior and Intervention Outcome in Young Children with Autism. Research in Developmental Disabilities. 29(5):446-458.
Ito T.  2009.  Children’s Toxicology from Bench to Bed – Liver Injury (1): Drug-Induced Metabolic Disturbance – Toxicity of 5-FU for Pyrimidine Metabolic Disorders and Pivalic Acid for Carnitine Metabolism. The Journal of Toxicological Sciences. 34(SP II):SP217-SP222. Abstract
Itzchak EB, Zachor DA.  2009.  Change in Autism Classification with Early Intervention: Predictors and Outcomes. Research in Autism Spectrum Disorders. 3(4):967-976. Abstract
Ivanov I, Klein M, Green WH, Coffey B.  2006.  The Challenges of Psychopharmacological Management of Children with Severe Developmental Disabilities. Journal of Child and Adolescent Psychopharmacology. 16(6):793-799.
|